Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Myofibroma 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

aldesleukin 2Adoptive Transfer 2trastuzumab deruxtecan 1talazoparib 1liposomal doxorubicin 1fludarabine 1dostarlimab 1belzutifan 1apixaban 1Vaccines, Synthetic 1Therapeutic Touch 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Specimen Handling 1Rivaroxaban 1Radiotherapy 1Radiation 1Papillomavirus Vaccines 1Paclitaxel 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Imiquimod 1Hysterectomy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Heparin, Low-Molecular-Weight 1Gemcitabine 1Fluorodeoxyglucose F18 1FAPI-46 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Vaginal Neoplasms × CA-125 Antigen × Clear all
NCT00005095 2025-02-28

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Northwestern University

Recruiting
6,000 enrolled
BreastGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡